Skip to main content
< Back to news
From left to right, Oriol Segarra and Alfons Nonell (Photo: Mind the Byte).

Oriol Segarra, CEO of Uriach, appointed member of the Board of Directors of Mind the Byte

Mind the Byte, located at the Barcelona Science Park, announces the designation of Oriol Segarra, CEO of the pharmaceutical company Uriach, as a new member of the board of directors. With this appointment, the bioinformatics company –specializing in computational drug discovery using Big Data, Artificial Intelligence and Machine Learning technologies– wants to accelerate its business plan for its growth and internationalisation. 


Oriol Segarra was born in Barcelona in 1971 and has an extensive background in strategic and management positions in the pharmaceutical sector, including Chief Operations Officer at Synthon. He holds an MBA from ESADE and has also attended postgraduate courses in executive development at Stanford, Harvard, IESE and the Université Catholique de Louvaine.

With his more than 20 years of business experience in global pharmaceutical companies, Segarra is an expert in leadership and change management. As the Chief Executive Officer of Uriach, he has led the transformation of the pharmaceutical company from a family firm to a successful transnational corporation.

“We are pleased to have Oriol Segarra join Mind the Byte as a board member, and look forward to his help in shaping the company’s growth,” said Alfons Nonell-Canals, founder and CEO of Mind the Byte. “He has tremendous experience and expertise in providing innovative solutions to address this challenge.”